- Issuer ticker
-
ENVB
- Reported as of
-
01 Jun 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
03 Jun 2026, 16:30:34 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Frank Pasqualone
Key filing fact
Frank Pasqualone filed Form 4 for Enveric Biosciences, Inc. (ENVB) on 03 Jun 2026.
Key facts
- This page summarizes Frank Pasqualone's Form 4 filing for Enveric Biosciences, Inc. (ENVB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2026, 16:30.
Change
- Previous filing in this sequence was filed on 30 Dec 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001597334
Primary reporting owner
PASQUALONE FRANK
- Relationship
-
Director
- Address
- 245 FIRST STREET, RIVERVIEW II, 18TH FLOOR, CAMBRIDGE
- Signature
- /s/ Frank Pasqualone
- Signature date
- 03 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ENVB
transaction
Common Stock
Award
- Transaction value
- Shares
- +18,518
- Change %
- +234%
- Price
-
$0.000000*
- Shares after
- 26,423
- Date
- 01 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote